{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:27:26Z","timestamp":1791862046941,"version":"4.3.4"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>This study explored the differences in clinical characteristics between the 2009 pandemic influenza A (H1N1) and SARS-CoV-2 BA.2 variant (Omicron) infections in patients younger than age 65 years, to improve identification of these diseases and better respond to the current epidemic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data from 127 patients with the 2009 pandemic influenza A (H1N1) diagnosed between May and July of 2009 and 3,265 patients with Omicron diagnosed between March and May of 2022 were collected. Using a 1:2 match based on age (difference &amp;lt;2 years), sex, and underlying diseases, data from 115 patients with the 2009 pandemic influenza A (H1N1) infection (H1N1 group) and 230 patients with SARS-CoV-2 Omicron BA.2 infection (Omicron group) were analyzed. The clinical manifestations were compared between the groups, logistic regression was performed to identify possible independent risk factors for each group, and multiple linear regression was used to analyze the factors predicting time for nucleic acid negativization (NAN).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median [interquartile range] age of the two groups was 21 [11, 26] years. Compared with the H1N1 group, the Omicron group had: lower white blood cell counts and C-reactive protein levels; less fever, nasal congestion, sore throat, cough, sputum, and headache; and more olfactory loss, muscle soreness, and lactate dehydrogenase (LDH) abnormalities. Patients in the Omicron group used fewer antibiotics and antiviral drugs, and the time for NAN was longer (17 [14,20] VS 4 [3,5] days, P&amp;lt;0.001). Logistic regression showed that fever, cough, headache, and increased white blood cell count were more strongly correlated with the H1N1 group, while muscle soreness and LDH abnormalities were more strongly correlated with the Omicron group. Fever (B 1.529, 95% confidence interval [0.149,2.909], P=0.030) significantly predicted a longer time for NAN in patients with Omicron.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>There are significant differences in clinical characteristics between SARS-CoV-2 Omicron infection and the 2009 pandemic influenza A (H1N1) infection. Recognition of these differences has important implications for clinical practice.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2023.1179552","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T09:52:52Z","timestamp":1689673972000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Distinguishing COVID-19 from seasonal influenza in patients under age 65 years\u2014a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics"],"prefix":"10.3389","volume":"13","author":[{"given":"Wen","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiang","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baosong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nengluan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongpeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e00130","DOI":"10.1128\/JVI.00130-21","article-title":"Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract","volume":"95","author":"Alfi","year":"2021","journal-title":"J. Virol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28441","article-title":"Efficacy and safety of nirmatrelvir\/ritonavir (Paxlovid) for COVID-19: a rapid review and meta-analysis","volume":"95","author":"Amani","year":"2023","journal-title":"J. Med. Virol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1018516","article-title":"A diagnostic model for serious COVID-19 infection among older adults in Shanghai during the Omicron wave","volume":"9","author":"Bao","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/INF.0b013e3181bc23fd","article-title":"Influenza is a major contributor to childhood pneumonia in a tropical developing country","volume":"29","author":"Brooks","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/S2213-2600(21)00559-2","article-title":"Omicron variant and booster COVID-19 vaccines","volume":"10","author":"Burki","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"B7","first-page":"1071","article-title":"Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza a (H1N1) - United States, may-august 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3760\/cma.j.issn.1001-0939.2010.02.001","article-title":"Clinical features of 127 cases of novel influenza a (H1N1) infection in Fujian province","volume":"33","author":"Chen","year":"2010","journal-title":"Chin. J. Tuberculosis Respir. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","article-title":"Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality 2020-21","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-020-0962-9","article-title":"Age-dependent effects in the transmission and control of COVID-19 epidemics","volume":"26","author":"Davies","year":"2020","journal-title":"Nat. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza a H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.ajpath.2021.05.010","article-title":"Human type II taste cells express angiotensin-converting enzyme 2 and are infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"191","author":"Doyle","year":"2021","journal-title":"Am. J. Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.16505\/j.2095-0136.2022.0023","article-title":"New coronavirus pneumonia diagnosis and treatment plan (trial version 9)","volume":"12","year":"2022","journal-title":"China Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s12276-021-00603-0","article-title":"The evolution and future of influenza pandemic preparedness","volume":"53","author":"Harrington","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11082246","article-title":"Comparison of clinical features and outcomes between SARS-CoV-2 and non-SARS-CoV-2 respiratory viruses associated acute respiratory distress syndrome: retrospective analysis","volume":"11","author":"Heo","year":"2022","journal-title":"JCM"},{"key":"B17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1001\/jamaneurol.2022.0154","article-title":"Postmortem assessment of olfactory tissue degeneration and microvasculopathy in patients with COVID-19","volume":"79","author":"Ho","year":"2022","journal-title":"JAMA Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1056\/NEJMc2214302","article-title":"Efficacy of antiviral agents against Omicron subvariants BQ.1.1 and XBB","volume":"388","author":"Imai","year":"2023","journal-title":"N Engl. J. Med."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2545","article-title":"Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments","volume":"348","author":"Jefferson","year":"2014","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021690","article-title":"Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza","volume":"6","author":"Karageorgopoulos","year":"2011","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30425","article-title":"Management of anosmia in COVID-19: a comprehensive review","volume":"14","author":"Khurana","year":"2022","journal-title":"Cureus"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e2365","DOI":"10.1002\/rmv.2365","article-title":"Respiratory viral co-infections in patients with COVID-19 and associated outcomes: a systematic review and meta-analysis","volume":"33","author":"Krumbein","year":"2022","journal-title":"Rev. Med. Virol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"B24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bsheal.2021.08.003","article-title":"Expression pattern and function of SARS-CoV-2 receptor ACE2","volume":"3","author":"Li","year":"2021","journal-title":"Biosaf Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ijid.2020.11.127","article-title":"Systematically comparing COVID-19 with the 2009 influenza pandemic for hospitalized patients","volume":"102","author":"Li","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.988694","article-title":"The effects of vaccination on the disease severity and factors for viral clearance and hospitalization in Omicron-infected patients: a retrospective observational cohort study from recent regional outbreaks in China","volume":"12","author":"Li","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11121531","article-title":"Progress of the COVID-19: persistence, effectiveness, and immune escape of the neutralizing antibody in convalescent serum","volume":"11","author":"Liang","year":"2022","journal-title":"Pathogens"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1080\/22221751.2022.2109517","article-title":"Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave","volume":"11","author":"Lu","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2196\/35763","article-title":"Has Omicron changed the evolution of the pandemic","volume":"8","author":"Lundberg","year":"2022","journal-title":"JMIR Public Health Surveill"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e23685","DOI":"10.1002\/jcla.23685","article-title":"Differential diagnosis of coronavirus disease 2019 pneumonia or influenza a pneumonia by clinical characteristics and laboratory findings","volume":"35","author":"Lv","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"B31","unstructured":"Diagnosis and treatment of influenza a (H1N1) (Trial version) issued by ministry of health2009"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/gbe\/evab196","article-title":"Causes and consequences of purifying selection on SARS-CoV-2","volume":"13","author":"Morales","year":"2021","journal-title":"Genome Biol. Evol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1056\/NEJMoa0903810","article-title":"Emergence of a novel swine-origin influenza a (H1N1) virus in humans","volume":"360","year":"2009","journal-title":"N Engl. J. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1007\/s10072-020-04708-8","article-title":"Neuromuscular presentations in patients with COVID-19","volume":"41","author":"Paliwal","year":"2020","journal-title":"Neurological Sci."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2022.100075","article-title":"Ambulation capacity, age, immunosuppression, and mechanical ventilation are risk factors of in-hospital death in severe COVID-19: a cohort study","volume":"77","author":"Silva","year":"2022","journal-title":"Clinics (Sao Paulo)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1644110","article-title":"T Cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors","volume":"8","author":"Simnica","year":"2019","journal-title":"Oncoimmunology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.15585\/mmwr.mm7142a3","article-title":"Effectiveness of monovalent mRNA vaccines against COVID-19-Associated hospitalization among immunocompetent adults during BA.1\/BA.2 and BA.4\/BA.5 predominant periods of SARS-CoV-2 Omicron variant in the united states - IVY network, 18 states, December 26, 2021-august 31, 2022","volume":"71","author":"Surie","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1056\/NEJMc2211845","article-title":"In vitro efficacy of antiviral agents against Omicron subvariant BA.4.6","volume":"387","author":"Takashita","year":"2022","journal-title":"N Engl. J. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1056\/NEJMc2207519","article-title":"Efficacy of antibodies and antiviral drugs against Omicron BA.2.12.1, BA.4, and BA.5 subvariants","volume":"387","author":"Takashita","year":"2022","journal-title":"N Engl. J. Med."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069503","article-title":"Prognosis and persistence of smell and taste dysfunction in patients with COVID-19: meta-analysis with parametric cure modelling of recovery curves","volume":"378","author":"Tan","year":"2022","journal-title":"BMJ"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23041987","article-title":"Omicron genetic and clinical peculiarities that may overturn SARS-CoV-2 pandemic: a literature review","volume":"23","author":"Tiecco","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4065\/mcp.2009.0615","article-title":"Influenza vaccines: from surveillance through production to protection","volume":"85","author":"Tosh","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"B43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","article-title":"Antibody evasion by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4 and BA.5","volume":"608","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00760-x","article-title":"Safety and efficacy of paxlovid against omicron variants of coronavirus disease 2019 in elderly patients","volume":"12","author":"Weng","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 omicron variant","volume":"185","author":"Wf","year":"2022","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for covid-19 - interim WHO solidarity trial results","volume":"384","author":"Pan","year":"2021","journal-title":"N Engl. J. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","article-title":"Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study","volume":"399","author":"Wolter","year":"2022","journal-title":"Lancet"},{"key":"B49","unstructured":"Weekly epidemiological update on COVID-19 - 25 January 20232023"},{"key":"B50","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cell.2022.11.030","article-title":"SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming","volume":"186","author":"Wu","year":"2023","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/odi.14300","article-title":"Chemosensory loss in COVID-19","volume":"28","author":"Xu","year":"2022","journal-title":"Oral. Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.3760\/cma.j.cn112137-20220708-01513","article-title":"Research progress on the proportion and characteristics of asymptomatic infection with novel coronavirus","volume":"102","author":"Yang","year":"2022","journal-title":"Natl. Med. J. China"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.847836","article-title":"Distinguishing COVID-19 from influenza pneumonia in the early stage through CT imaging and clinical features","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281812","article-title":"The impact of the COVID-19 pandemic and the expansion of free vaccination policy on influenza vaccination coverage: an analysis of vaccination behavior in South Korea","volume":"18","author":"Yeo","year":"2023","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1002\/jmv.26163","article-title":"The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak","volume":"92","author":"Yue","year":"2020","journal-title":"J. Med. Virol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.cell.2022.01.024","article-title":"Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia","volume":"185","author":"Zazhytska","year":"2022","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12916-022-02397-y","article-title":"Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis","volume":"20","author":"Zeng","year":"2022","journal-title":"BMC Med."},{"key":"B58","first-page":"2651","article-title":"Clinical features of initial cases of 2009 pandemic influenza a (H1N1) in Macau, China","volume":"123","author":"Zhou","year":"2010","journal-title":"Chin. Med. J. (Engl)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1802406","DOI":"10.1183\/13993003.02406-2018","article-title":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China network","volume":"54","author":"Zhou","year":"2019","journal-title":"Eur. Respir. J."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1179552\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T09:53:04Z","timestamp":1689673984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1179552\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":59,"alternative-id":["10.3389\/fcimb.2023.1179552"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1179552","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,18]]},"article-number":"1179552"}}